The global Lennox-Gastaut Syndrome Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Lennox?Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3?5 years and can persist into adulthood.
Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-lennoxgastaut-syndrome-treatment-forecast-2023-2030-742
This report aims to provide a comprehensive presentation of the global market for Lennox-Gastaut Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lennox-Gastaut Syndrome Treatment. This report contains market size and forecasts of Lennox-Gastaut Syndrome Treatment in global, including the following market information:
Global Lennox-Gastaut Syndrome Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
We surveyed the Lennox-Gastaut Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lennox-Gastaut Syndrome Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Lennox-Gastaut Syndrome Treatment Market Segment Percentages, by Type, 2022 (%)
Non-surgical Treatment
Surgical Treatment
Global Lennox-Gastaut Syndrome Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Lennox-Gastaut Syndrome Treatment Market Segment Percentages, by Application, 2022 (%)
Seizures
Ocular Abnormality
EEG Findings
Others
Global Lennox-Gastaut Syndrome Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Lennox-Gastaut Syndrome Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lennox-Gastaut Syndrome Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lennox-Gastaut Syndrome Treatment revenues share in global market, 2022 (%)
Key players include:
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lennox-Gastaut Syndrome Treatment, market overview.
Chapter 2: Global Lennox-Gastaut Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Lennox-Gastaut Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lennox-Gastaut Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-lennoxgastaut-syndrome-treatment-forecast-2023-2030-742
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Comentários